Cargando…
Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy
Rheumatoid arthritis (RA) is the most commonly occurring chronic inflammatory arthritis, the exact mechanism of which is not fully understood. Tumor Necrosis Factor (TNF)-targeting drugs has been shown to exert high effectiveness for RA, which indicates the key importance of this cytokine in this di...
Autores principales: | Wysocki, Tomasz, Paradowska-Gorycka, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879844/ https://www.ncbi.nlm.nih.gov/pubmed/35216481 http://dx.doi.org/10.3390/ijms23042366 |
Ejemplares similares
-
Current Understanding of an Emerging Role of HLA-DRB1 Gene in Rheumatoid Arthritis–From Research to Clinical Practice
por: Wysocki, Tomasz, et al.
Publicado: (2020) -
miRNAs as Biomarkers and Possible Therapeutic Strategies in Rheumatoid Arthritis
por: Kmiołek, Tomasz, et al.
Publicado: (2022) -
AHR-dependent genes and response to MTX therapy in rheumatoid arthritis patients
por: Wajda, Anna, et al.
Publicado: (2021) -
The role of cell-free circulating microRNA in diagnostics in patients with rheumatoid arthritis
por: Paradowska-Gorycka, Agnieszka, et al.
Publicado: (2016) -
VAV1 Gene Polymorphisms in Patients with Rheumatoid Arthritis
por: Pawlik, Andrzej, et al.
Publicado: (2020)